Don't miss the first issue of our new twice-monthly publication dedicated to cell and gene therapy. Cell and Gene Therapy Business Outlook offers the following:
Market Sizing and Forecasting of CAGT Markets
Executive News Summaries
Deals Between CAGT Companies Tracked
Financing
Trends in the Industry
Important Science That Will Shape Tomorrow’s Business
Company Profiling and Quarterly Results Summaries
Updates on Pipelines and Important Clinical Trials
Cell and Gene Therapy Tools
Cell and Gene Therapy CMOs
And More
Page Count: 64
Table of Contents
Untitled Chapter
Why You Are Receiving This Issue
Oncology Market Analysis: Strong Increase in CAR-T, Blood Cancers
Market Outlook
Products
Introduction
Products on the Market
Products in Development
Oncology Market Opportunity
Market Size and Growth
Top Company Briefs
Executive News Brief
Recent developments in cell and gene therapy
Cell and Gene Therapy Market Financing
2.8 Billion in CGT Financing Since March 1st
Cell and Gene Therapy Market News and News Analysis
Sorrento and Karolinska Institutet Collaborate on iPSC-Derived Dimeric Antigen Receptor-Modified Natural Killer (DAR-NK) Cells
Another "Go-To" Example of CGT Success in Treatment of ADA-SCID; Challenges Remain
BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Form Alliance to Develop New Cell Therapies For Eye Diseases
FDA Grants Approval for Bristol-Myers Squibb’s CAR-T Cell Therapy, Breyanzi; Legal Challenges Complicate Field
Biogen and Capsigen Announce Collaboration to Engineer Novel AAV Capsids
Charles River Laboratories to Acquire Vigene Biosciences
CRISPR Therapeutics and Nkarta Announce Partnership to Develop Gene-Edited Cell Therapies for Cancer
Two Antisense Strategies for Huntington’s Disease Halt Clinical Trials
FDA Fast Tracks LX1001, New Investigational Gene Therapy Treatment for Alzheimer’s Disease
Cell and Gene Therapy Market Corporate Profiles and Quarterly Results
The SDi Global Assessment Report 2020: The Laboratory Analytical & Life Science Instrumentation Industry is the gold standard for market research reports in the analytical and life science instrument market.
Updated June 2020 to reflect the COVID-1…